Peer Review History
| Original SubmissionSeptember 23, 2020 |
|---|
|
Dear Prof. Martinelli, Thank you very much for submitting your manuscript "Apoptosis mapping in space and time of 3D tumor ecosystems reveals transmissibility of cytotoxic cancer death" for consideration at PLOS Computational Biology. As with all papers reviewed by the journal, your manuscript was reviewed by members of the editorial board and by several independent reviewers. In light of the reviews (below this email), we would like to invite the resubmission of a significantly-revised version that takes into account the reviewers' comments. We cannot make any decision about publication until we have seen the revised manuscript and your response to the reviewers' comments. Your revised manuscript is also likely to be sent to reviewers for further evaluation. When you are ready to resubmit, please upload the following: [1] A letter containing a detailed list of your responses to the review comments and a description of the changes you have made in the manuscript. Please note while forming your response, if your article is accepted, you may have the opportunity to make the peer review history publicly available. The record will include editor decision letters (with reviews) and your responses to reviewer comments. If eligible, we will contact you to opt in or out. [2] Two versions of the revised manuscript: one with either highlights or tracked changes denoting where the text has been changed; the other a clean version (uploaded as the manuscript file). Important additional instructions are given below your reviewer comments. Please prepare and submit your revised manuscript within 60 days. If you anticipate any delay, please let us know the expected resubmission date by replying to this email. Please note that revised manuscripts received after the 60-day due date may require evaluation and peer review similar to newly submitted manuscripts. Thank you again for your submission. We hope that our editorial process has been constructive so far, and we welcome your feedback at any time. Please don't hesitate to contact us if you have any questions or comments. Sincerely, Inna Lavrik Associate Editor PLOS Computational Biology Florian Markowetz Deputy Editor PLOS Computational Biology *********************** Reviewer's Responses to Questions Comments to the Authors: Please note here if the review is uploaded as an attachment. Reviewer #1: In general, this is a very well written manuscript and the topic is certainly of interest to the readership of PLOS Comput. Biol. The computational method STAMP developed by the authors is envisioned to be a useful tool for the community for image analysis of apoptosis events, especially in the context of 3D culture. The authors not only clearly displayed the development of this algorithms, but also demonstrated its robustness and versatility via several case studies/applications. Here I have several comments regarding to this manuscript, which are listed based on page number: Page 4, under application to quantify chemotherapy-mediated cytotoxicity: the authors observed apoptosis rate fluctuated around 5% under control condition (Figure 2C), especially around 20-50 h, is that a normal apoptosis rate the author would expect? Page 5, under application to quantify T-cell mediated cytotoxicity: There seems to have some discrepancy between figure 3C and 4. In Figure 3C, coculture of IGR-Pub and CTL gave apoptosis rate around 15% at 20-30 h, while in Figure 4, the rate for interval 20-28 h is already over 40% (24% for 20-24 h+19% for 24-28 h). Seems like the authors are using the exact same set of videos for quantification, can the authors provide some explanation about this discrepancy? Page 5, under application to quantify T-cell mediated cytotoxicity: the authors indicated “after 2 days on chip the T cell viability was reduced (around 90 %)”. It would be better if the authors could provide more details in how to measure the viability for T-cells, either in this paragraph or in method. Page 5, under cancer-associated fibroblasts promote chemo-resistance: the authors need to provide statistical analysis for the four conditions in Figure 5, especially the conditions +dox/-CAF and +dox/+CAF. The curves looked different, however the difference might not be significant due to the error (curves were plotted using SEM, not SD). The same applied for Figure 4A and 4B. Page 5, under spatiotemporal analysis of cytotoxicity death: it would be clearer to define “nearby cells” here, eg. how close the dead event would be considered as a nearby event. Is the definition “one third of the estimated average cell radius” applied to all the quantification? Would cell density significantly affect the outcome? Also it would be interesting to see the result for MDA-MB-231 ±dox/+CAF in main text or supplementary info. Based on the result discussed in previous section, CAF impaired doxorubicin dependent apoptosis and therefore the Pdeath would be expected to be similar as natural death. Page 6, under the discussion for STAMP method, paragraph 2: Navg(t, TLAG), “N” should be italic Page 7, under the discussion for biological implications, paragraph 1: “in vitro” should be italic. “The CTL clone (P62) used is this work kills autologous cells (IGR-Pub)”, should be “used in this work” Page 8, methods for cell cultures: for cell line authentication, the authors presumably refer to STR profiling instead of SRT? Maybe spell out this abbreviation. Page 9, methods for live cell imaging: it would be better if the author could provide more details in setting up the time-lapse image acquisition, eg, wavelength, filter, exposure, etc. And seems like the way to position the AIM-Biotech devices is a key step in experimental setting. It would be helpful if the authors could provide some photos in supplementary info about this setting, which will enable easy application of this method by other audience. Page 12, the authors are using Mann-Whitney-Wilcoxon nonparametric test through the entire manuscript, however, the sample size (n=3) is too small to achieve any statistical meaning. As it is stated on the GraphPad’s website (https://www.graphpad.com/guides/prism/8/statistics/how_the_mann-whitney_test_works.htm), “If you have small samples, the Mann-Whitney test has little power. In fact, if the total sample size is seven or less, the Mann-Whitney test will always give a P value greater than 0.05 no matter how much the groups differ.” Also, in many figures, for example Figure 2C, it seems clear that MDA-MB-231 control 0-10, MDA-MB-231 doxorubicin 0-10/30-40 are different, however, due to the small sample size, there is no significant difference achieved. And therefore, the statement on page 4 “we never found statistically significant differences between automated and manual counting, indicating that the algorithm is validated with respect to a standard human-controlled quantification method” is not appropriate. The authors need to increase the sample size to support their statement. I would envision there would be significant difference between manual counts and automatic counts, can the author provide more details about why that would occur, and is there any improvement can be made. In addition, can the authors explain why they chose Mann-Whitney-Wilcoxon test instead of t test? And for the replicates, are they technical replicates (different views) or biological replicates (different samples)? I would recommend using biological replicates to achieve solid result. Page 19, figure 2B, please define blue arrow. Presumably the authors are indicating CTL cells? Also, I don’t find the info related to deposit of this software. It will be helpful if the authors could provide a link/user manual to guide the audience getting access to this tool. Reviewer #2: Manuscript PCOMPBIOL-D-20-01728 described new video analysis algorithms to reveal drug- or cell-induced cytotoxic effects (apoptosis) on human cancer cells in time and in space. The new method, abbreviated STAMP, has shown its applications to study the kinetics of cell death. The unsuspected finding of "death transmissibility" unveiled by this method is very interesting and warrants further mechanism studies. Overall, this manuscript has been well prepared. I recommend its publication in PLOS Computational Biology with no revisions. ********** Have all data underlying the figures and results presented in the manuscript been provided? Large-scale datasets should be made available via a public repository as described in the PLOS Computational Biology data availability policy, and numerical data that underlies graphs or summary statistics should be provided in spreadsheet form as supporting information. Reviewer #1: No: The authors did not provide detailed data yet for their analysis. Also, it would be helpful if the authors could provide a link for software deposit and guide the audience getting access to this tool. Reviewer #2: Yes ********** PLOS authors have the option to publish the peer review history of their article (what does this mean?). If published, this will include your full peer review and any attached files. If you choose “no”, your identity will remain anonymous but your review may still be made public. Do you want your identity to be public for this peer review? For information about this choice, including consent withdrawal, please see our Privacy Policy. Reviewer #1: No Reviewer #2: No Figure Files: While revising your submission, please upload your figure files to the Preflight Analysis and Conversion Engine (PACE) digital diagnostic tool, https://pacev2.apexcovantage.com. PACE helps ensure that figures meet PLOS requirements. To use PACE, you must first register as a user. Then, login and navigate to the UPLOAD tab, where you will find detailed instructions on how to use the tool. If you encounter any issues or have any questions when using PACE, please email us at figures@plos.org. Data Requirements: Please note that, as a condition of publication, PLOS' data policy requires that you make available all data used to draw the conclusions outlined in your manuscript. Data must be deposited in an appropriate repository, included within the body of the manuscript, or uploaded as supporting information. This includes all numerical values that were used to generate graphs, histograms etc.. For an example in PLOS Biology see here: http://www.plosbiology.org/article/info%3Adoi%2F10.1371%2Fjournal.pbio.1001908#s5. Reproducibility: To enhance the reproducibility of your results, PLOS recommends that you deposit laboratory protocols in protocols.io, where a protocol can be assigned its own identifier (DOI) such that it can be cited independently in the future. For instructions, please see http://journals.plos.org/compbiol/s/submission-guidelines#loc-materials-and-methods |
| Revision 1 |
|
Dear Prof. Martinelli, Thank you very much for submitting your manuscript "Apoptosis mapping in space and time of 3D tumor ecosystems reveals transmissibility of cytotoxic cancer death" for consideration at PLOS Computational Biology. As with all papers reviewed by the journal, your manuscript was reviewed by members of the editorial board and by several independent reviewers. The reviewers appreciated the attention to an important topic. Based on the reviews, we are likely to accept this manuscript for publication, providing that you modify the manuscript according to the review recommendations. Please prepare and submit your revised manuscript within 30 days. If you anticipate any delay, please let us know the expected resubmission date by replying to this email. When you are ready to resubmit, please upload the following: [1] A letter containing a detailed list of your responses to all review comments, and a description of the changes you have made in the manuscript. Please note while forming your response, if your article is accepted, you may have the opportunity to make the peer review history publicly available. The record will include editor decision letters (with reviews) and your responses to reviewer comments. If eligible, we will contact you to opt in or out [2] Two versions of the revised manuscript: one with either highlights or tracked changes denoting where the text has been changed; the other a clean version (uploaded as the manuscript file). Important additional instructions are given below your reviewer comments. Thank you again for your submission to our journal. We hope that our editorial process has been constructive so far, and we welcome your feedback at any time. Please don't hesitate to contact us if you have any questions or comments. Sincerely, Inna Lavrik Associate Editor PLOS Computational Biology Florian Markowetz Deputy Editor PLOS Computational Biology *********************** A link appears below if there are any accompanying review attachments. If you believe any reviews to be missing, please contact ploscompbiol@plos.org immediately: [LINK] Reviewer's Responses to Questions Comments to the Authors: Please note here if the review is uploaded as an attachment. Reviewer #1: The authors carefully addressed most of my comments and the manuscript got significant improved. It should be ready for acceptance for publication, here I just have a few minor points that I would like to further confirm with the authors: For T cell quantification, seems like the method is via manually counting. As this manuscript is all about developing an algorithm to simplify video analysis, is it possible to establish an automatic way to streamline the process? Or what is the difficulty in developing such method? Please discuss more in the manuscript. In terms of the definition about “nearby cells”, I am still a little confused, as I thought the parameter “r” restricts the event of nearby cells (death wake). While as the authors wrote in the response, it is included all the cells within the detection window? Can the authors provide more explanation towards this question? Also for the discrepancy between manual and automated counting, to me there is significant difference between this two groups at certain time point (in figure 2c). Please perform statistical test and specify accordingly on the figure. Looks like the discrepancy is more likely to occur at early time point, is there any reason why automated counting has lower readout at early time point? Why the algorithm failed to pick apoptotic cells which could be easily identified via manual counting? Please provide more discussion about this discrepancy. Reviewer #2: I have no further comments. The manuscript has been well revised with a high quality to be accepted by PLOS Computational Biology. ********** Have all data underlying the figures and results presented in the manuscript been provided? Large-scale datasets should be made available via a public repository as described in the PLOS Computational Biology data availability policy, and numerical data that underlies graphs or summary statistics should be provided in spreadsheet form as supporting information. Reviewer #1: Yes Reviewer #2: Yes ********** PLOS authors have the option to publish the peer review history of their article (what does this mean?). If published, this will include your full peer review and any attached files. If you choose “no”, your identity will remain anonymous but your review may still be made public. Do you want your identity to be public for this peer review? For information about this choice, including consent withdrawal, please see our Privacy Policy. Reviewer #1: No Reviewer #2: No Figure Files: While revising your submission, please upload your figure files to the Preflight Analysis and Conversion Engine (PACE) digital diagnostic tool, https://pacev2.apexcovantage.com. PACE helps ensure that figures meet PLOS requirements. To use PACE, you must first register as a user. Then, login and navigate to the UPLOAD tab, where you will find detailed instructions on how to use the tool. If you encounter any issues or have any questions when using PACE, please email us at figures@plos.org. Data Requirements: Please note that, as a condition of publication, PLOS' data policy requires that you make available all data used to draw the conclusions outlined in your manuscript. Data must be deposited in an appropriate repository, included within the body of the manuscript, or uploaded as supporting information. This includes all numerical values that were used to generate graphs, histograms etc.. For an example in PLOS Biology see here: http://www.plosbiology.org/article/info%3Adoi%2F10.1371%2Fjournal.pbio.1001908#s5. Reproducibility: To enhance the reproducibility of your results, PLOS recommends that you deposit laboratory protocols in protocols.io, where a protocol can be assigned its own identifier (DOI) such that it can be cited independently in the future. For instructions see http://journals.plos.org/ploscompbiol/s/submission-guidelines#loc-materials-and-methods |
| Revision 2 |
|
Dear Prof. Martinelli, We are pleased to inform you that your manuscript 'Apoptosis mapping in space and time of 3D tumor ecosystems reveals transmissibility of cytotoxic cancer death' has been provisionally accepted for publication in PLOS Computational Biology. Before your manuscript can be formally accepted you will need to complete some formatting changes, which you will receive in a follow up email. A member of our team will be in touch with a set of requests. Please note that your manuscript will not be scheduled for publication until you have made the required changes, so a swift response is appreciated. IMPORTANT: The editorial review process is now complete. PLOS will only permit corrections to spelling, formatting or significant scientific errors from this point onwards. Requests for major changes, or any which affect the scientific understanding of your work, will cause delays to the publication date of your manuscript. Should you, your institution's press office or the journal office choose to press release your paper, you will automatically be opted out of early publication. We ask that you notify us now if you or your institution is planning to press release the article. All press must be co-ordinated with PLOS. Thank you again for supporting Open Access publishing; we are looking forward to publishing your work in PLOS Computational Biology. Best regards, Inna Lavrik Associate Editor PLOS Computational Biology Florian Markowetz Deputy Editor PLOS Computational Biology *********************************************************** |
| Formally Accepted |
|
PCOMPBIOL-D-20-01728R2 Apoptosis mapping in space and time of 3D tumor ecosystems reveals transmissibility of cytotoxic cancer death Dear Dr Martinelli, I am pleased to inform you that your manuscript has been formally accepted for publication in PLOS Computational Biology. Your manuscript is now with our production department and you will be notified of the publication date in due course. The corresponding author will soon be receiving a typeset proof for review, to ensure errors have not been introduced during production. Please review the PDF proof of your manuscript carefully, as this is the last chance to correct any errors. Please note that major changes, or those which affect the scientific understanding of the work, will likely cause delays to the publication date of your manuscript. Soon after your final files are uploaded, unless you have opted out, the early version of your manuscript will be published online. The date of the early version will be your article's publication date. The final article will be published to the same URL, and all versions of the paper will be accessible to readers. Thank you again for supporting PLOS Computational Biology and open-access publishing. We are looking forward to publishing your work! With kind regards, Katalin Szabo PLOS Computational Biology | Carlyle House, Carlyle Road, Cambridge CB4 3DN | United Kingdom ploscompbiol@plos.org | Phone +44 (0) 1223-442824 | ploscompbiol.org | @PLOSCompBiol |
Open letter on the publication of peer review reports
PLOS recognizes the benefits of transparency in the peer review process. Therefore, we enable the publication of all of the content of peer review and author responses alongside final, published articles. Reviewers remain anonymous, unless they choose to reveal their names.
We encourage other journals to join us in this initiative. We hope that our action inspires the community, including researchers, research funders, and research institutions, to recognize the benefits of published peer review reports for all parts of the research system.
Learn more at ASAPbio .